MGTX - MeiraGTx Holdings to launch ~$60M equity offering
2023-05-03 09:13:39 ET
- Gene therapy company MeiraGTx Holdings ( NASDAQ: MGTX ) has agreed to sell ~10.7M shares at $5.75 per share for aggregate gross proceeds of ~$60M.
- The company intends to use the proceeds to continue to advance its pipeline of gene therapy assets, as well as for general corporate purposes.
- The financing was entirely led by the company's top holders Perceptive Advisors, Adage Capital, Prosight Management and 683 Capital Management.
- The private placement is expected to close on or about May 5.
- MGTX shares were trading +12.72% pre-market.
- Source: Press Release
For further details see:
MeiraGTx Holdings to launch ~$60M equity offering